DOI:
10.1055/s-00042229
Geriatrie up2date
LinksClose Window
References
Chabriat H, Bassetti CL, Marx U. et al.
Safety and efficacy of GABAA alpha5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.
Lancet Neurol 2020;
19: 226-233
DOI: 10.1016/S1474-4422(20)30004-1. (PMID: 32085836)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.